{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T04:40:05Z","timestamp":1752468005986,"version":"3.41.2"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2025.1607955","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T04:10:35Z","timestamp":1752466235000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Concerns and recommendations: antiplatelet agents and cancer prevention in non-alcoholic fatty liver disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Hong Tham","family":"Pham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim-Huong","family":"Truong-Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh-Hoang","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12916-024-03802-4","article-title":"The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study","volume":"22","author":"Anson","year":"2024","journal-title":"BMC Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.124.319863","article-title":"Cardiovascular disease and cancer: A dangerous liaison","volume":"45","author":"Newman","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/tp.0000000000002361","article-title":"Should patients with NAFLD\/NASH be surveyed for HCC","volume":"103","author":"Reig","year":"2019","journal-title":"Transplantation"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2016.07.017","article-title":"Immortal time bias in observational studies of time-to-event outcomes","volume":"36","author":"Jones","year":"2016","journal-title":"J Crit Care"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi307","article-title":"Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods","volume":"162","author":"Zhou","year":"2005","journal-title":"Am J Epidemiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1017\/pan.2019.11","article-title":"Why propensity scores should not be used for matching","volume":"27","author":"King","year":"2019","journal-title":"Political Anal"},{"key":"B7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1186\/s12879-024-09866-0","article-title":"Co-infections and secondary infections amid COVID-19 outbreaks in Vietnam","volume":"24","author":"Pham","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67256","article-title":"Step-based dosing of anticoagulants in COVID-19 treatment","volume":"16","author":"Tran","year":"2024","journal-title":"Cureus"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/0962280219892295","article-title":"Comparison of the marginal hazard model and the sub-distribution hazard model for competing risks under an assumed copula","volume":"29","author":"Emura","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.79","article-title":"Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care","volume":"104","author":"Peto","year":"2011","journal-title":"Br J Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92833-4","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2","volume":"332","year":"1988","journal-title":"Lancet"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1607955\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T04:10:36Z","timestamp":1752466236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1607955\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":12,"alternative-id":["10.3389\/fonc.2025.1607955"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1607955","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"article-number":"1607955"}}